Overview

Human Factors Study of Methotrexate Prefilled Pen (50 mg/mL) in Patients With Juvenile Idiopathic Arthritis

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This study is planned to evaluate the human factor (HF)/usability of pediatric or adolescent JIA patients and the caregivers of Juvenile Idiopathic Arthritis (JIA) patients with the Methotrexate Prefilled Pen (including a label comprehension assessment and a device robustness evaluation).
Phase:
N/A
Details
Lead Sponsor:
medac GmbH
Collaborator:
PPD
Treatments:
Methotrexate